Expect FDA Diagnostics-Reform Bill Passage In 2019, Rep. DeGette Says

Passage of a US FDA diagnostics reform bill is one priority for the US House Energy and Commerce Committee in 2019, said cosponsor and committee member Rep. Diana Degette, D-Colo.

Capitol Building, Washington, US, mirrored reflection

Diagnostics regulatory reform is on the agenda of the US House Energy and Commerce Committee this year, Rep. Diana DeGette, D-Colo., told Medtech Insight following a Jan. 16 Alliance for Health Policy briefing in Washington, DC. DeGette is a senior member of the committee and the new chair of the E&C Oversight and Investigations Subcommittee.

DeGette (pictured, right) suggested that the ‘Verifying Accurate Leading-edge IVCT Development Act’ (VALID Act), a proposed diagnostics reform bill developed...

More from Legislation

More from Policy & Regulation